Sentante has begun commercial deployment of its CE-marked endovascular robotic platform, the medical robotics company announced on August 20, 2026, with vascular surgery and interventional radiology as its first clinical markets. The move takes the Kaunas-based company from regulatory clearance into revenue-generating clinical use three months after its CE mark, granted in May 2026. The announcement frames the commercial rollout as the start of the company's physical AI strategy: every… [...]
While many enterprises have already begun integrating AI-generated images, visuals, graphics and videos into their production workflows — there is also a growing pool of data and subjective commenta [...]
CES always has its share of attention-grabbing robots. But this year in particular seemed to be a landmark year for robotics. The advancement in AI technology has not only given robots better “brain [...]
Chinese AI startup Moonshot AI, creators of the increasingly famous "Kimi K" family of powerful, open AI models, today released the full weights for its largest and most performant version y [...]